Pages that link to "Q44822122"

The following pages link to Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor (Q44822122):

Displaying 24 items.

• Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP) (Q28080057) (← links)
• Diabetic cardiomyopathy: pathophysiology and clinical features (Q30457504) (← links)
• Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes (Q34129753) (← links)
• Role of the Mitochondrion in Programmed Necrosis (Q34691909) (← links)
• Chromatin remodeling in cardiovascular development and physiology (Q34814306) (← links)
• Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress (Q35955745) (← links)
• Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors (Q36111918) (← links)
• Nitrosative stress and pharmacological modulation of heart failure (Q36145124) (← links)
• The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity (Q36165860) (← links)
• Silencing of Apoptosis-Inducing factor and poly(ADP-ribose) glycohydrolase reveals novel roles in breast cancer cell death after chemotherapy (Q36388268) (← links)
• Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors (Q36426742) (← links)
• Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. (Q36464461) (← links)
• PARP inhibitors and heart failure--translational medicine caught in the act. (Q36773354) (← links)
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond (Q36853236) (← links)
• Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats (Q36988132) (← links)
• Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction (Q37230827) (← links)
• Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK-mediated AIF translocation (Q37398277) (← links)
• Molecular mechanisms of cardiomyocyte aging (Q37893685) (← links)
• Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus (Q39398383) (← links)
• INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin (Q40107480) (← links)
• Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases. (Q45969399) (← links)
• Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. (Q55663138) (← links)
• Activation of Cell Death Mediated by Apoptosis-Inducing Factor Due to the Absence of Poly(ADP-ribose) Glycohydrolase (Q83511843) (← links)
• Poly(ADP-ribose) polymerase inhibition: past, present and future (Q98945207) (← links)